Valuation : Masimo Corporation

Market Cap 9.42B 8.12B 7.69B 6.97B 13.07B 900B 13.14B 91.31B 35.11B 458B 35.39B 34.61B 1,447B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.47B 8.02B 7.27B 13.64B 939B 13.71B 95.25B 36.63B 478B 36.92B 36.11B 1,510B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
6 months+2.54%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 03/08/2026
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 10/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
10/06/26 Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
23/04/26 Exercice

Director

3,569 0.0068%
23/04/26 Exercice

Director

3,569 0.0068%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+23.41%+70.78% 9.42B
-0.02%-1.38%+14.95%+5.90% 12.52B
-0.59%-4.01%+11.25%+26.12% 6.65B
+0.27%-3.37% - - 6.31B
-1.39%-11.59%+18.43%+8.48% 5.57B
+1.23%-0.49%-20.59%+42.68% 4.98B
-0.24%-1.21%-36.02%-22.57% 3.77B
-1.45%+2.69%-4.39%+133.27% 1.82B
+1.04%-13.55%+21.84%-24.30% 1.79B
-1.07%-2.99%+40.67%-20.59% 1.59B
Average -0.16%-3.15%+7.73%+24.42% 5.44B
Weighted average by Cap. -0.06%-2.68%+9.20%+26.09%

Financials

2024 2025
Net sales 2.09B 1.8B 1.71B 1.55B 2.91B 200B 2.92B 20.29B 7.8B 102B 7.87B 7.69B 322B 1.53B 1.32B 1.25B 1.13B 2.12B 146B 2.13B 14.79B 5.69B 74.21B 5.73B 5.61B 235B
Net income -305M -263M -249M -225M -423M -29.13B -425M -2.95B -1.14B -14.82B -1.15B -1.12B -46.83B -152M -131M -124M -112M -210M -14.47B -211M -1.47B -564M -7.36B -569M -556M -23.27B
Net Debt 668M 576M 545M 494M 927M 63.87B 932M 6.48B 2.49B 32.49B 2.51B 2.46B 103B 407M 351M 332M 301M 565M 38.88B 567M 3.94B 1.52B 19.78B 1.53B 1.49B 62.51B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!